Although there is limited number of data supporting alteration in CTRP3 metabolic disorders, no study has specifically assessed the association of CTRP13 circulating levels and peripheral blood mononuclear cells (PBMCs) gene expression with metabolic status in T2DM patients. Here, C1QL3 is linked to type 2 diabetes mellitus.